Skip to main content
Premium Trial:

Request an Annual Quote

Quebec Research Center Receives $12.8M for Gene Expression Study of Steriod Use

SAN FRANCISCO, Dec. 20 - The Centre Hospitalier Universitaire de Quebec received a commitment for $10 million Canadian ($6.4 million) each from Genome Quebec and Genome Canada to fund a project to study the changes in gene expression that occur from steroid treatment.


The funding is part of $40 million Canadian ($25.3 million) earmarked for Quebec by Genome Canada, the Canadian genomics research organization. Genome Quebec is the provincial arm of Genome Canada.


"Dr. Labrie's [of CHUQ] research work will lead to a better basic understanding of steroids' impact on the human genome and open up new and significant progress opportunities in the fight against disease," Martin Godbout, CEO of Genome Canada, said in a statement.

The Scan

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.

Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes

Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus.

Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences

With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities.

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.